News | July 30, 2008

Cath Labs Turn Patients Away if They are Too Obese

July 31, 2008 – A survey of cardiovascular catheterization laboratories in the U.S. found obese patients who weigh more than the cath lab’s equipment limits are referred to other facilities at 22 percent of those surveyed, but 70 percent could not answer the question.

The telephone survey results were published this week in the Aug. 1 issue of the American Journal of Cardiology.

The survey was performed to determine the current weight limits of 94 cath labs in the U.S. The minimum weight limit was 350 pounds, the mean limit was 437.5 pounds, and maximum weight limit was 550 pounds.
If a patient does exceed the weight limit of the cath lab’s table, 21 facilities said they referred the patient to other institutions. However, 66 respondents could not provide an answer. The survey showed in this population, 5.2 ± 3.4 patients/hospital/year were rejected for being over the weight limit.

The authors, Thomas E. Vanhecke, M.D., Aaron D. Berman, M.D., Peter A. McCullough, M.D., MPH, of the division of cardiology, department of internal medicine, William Beaumont Hospital, Royal Oak, MI, hope the results provide useful information for the future management of the growing obese population.

For more information: www.ajconline.org


Related Content

News | Cardiovascular Clinical Studies

May 2, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular ...

Home May 02, 2024
Home
News | Cardiovascular Clinical Studies

May 1, 2024 — A study in more than 3,000 US counties, with 315 million residents, has suggested that air pollution is ...

Home May 01, 2024
Home
News | Cardiovascular Clinical Studies

April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart ...

Home April 30, 2024
Home
News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
Subscribe Now